Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Share Issue/Capital Change 2021

Oct 20, 2021

66262_rns_2021-10-20_5cb03a8c-b68b-4bfe-af9c-946153c1745a.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

MARKET ANNOUNCEMENT

==> picture [133 x 77] intentionally omitted <==

19[th] October 2021

Notice of issue of options under Rua Bioscience Limited’s share option plan

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of options ( Options ) to acquire ordinary shares in Rua Bioscience Limited (the Company ) pursuant to the terms of the share option plan of the Company (the Share Option Plan ).

This notice provides details of the issue of 2,486,400 Options to selected eligible employees of the Company pursuant to the rules of the Share Option Plan.

Section 1: Issuer information

Section 1: Issuer information Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Options to acquire ordinary shares in theCompany
ISIN (If unknown, check on NZX website) NZRUAE0004S1. The Options will not bequoted.
Currency NZD
Section 2: Capital change details
Number of Options issued 2,486,400
Issue price per Option No cash consideration is payable for theissue of the Options
Nature of the payment (for example, cash or otherconsideration) Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Options issued 100% of all Options of the same classcurrently on issue.
The principal terms of the Options Subject to the rules of the Share OptionPlan and achievement of certainperformance hurdles assessed on 30 June2024 (Vesting Date), each Option holderwill be able to exercise: one third of theirvested Options in the period from theVesting Date to the date that is onecalendar month after the Vesting Date;one third of their vested Options in theperiod from the first anniversaryof the
Vesting Date to the date that is onecalendar month after the first anniversaryof the Vesting Date; and one third of theirvested Options in the period from thesecond anniversary of the Vesting Date tothe date that is one calendar month afterthe second anniversary of the VestingDate.The exercise price is nil.
Reason for issue of the Options The board of the Company resolved tooffer Options to participants for thepurpose of:(a) enabling the Company to recruit andretain highly qualified personnel;(b) incentivising increased productivity;and(c) providing the participants with anopportunity to share in the growth andvalue of the Company.
Total number of Options of the same class in existenceafter the issue of the Options 2,486,400 Options following the issue ofthe Options
Specific authority for the issue of the Options Directors’ resolution dated 15thOctober2021. The Options were issued inaccordance with Listing Rules 4.6 and 4.11.
Terms of the issue of the Options The new ordinary shares issued upon theexercise of the Options will be credited asfully paid, and rank in all respects equallywith the ordinary shares already on issueand will otherwise be issued in accordancewith the vesting requirements and termsof the Share Option Plan
Date of issue of the Options 18/10/2021
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Hamish White, Chief Financial Officer ofRua Bioscience Limited
Contact person for this announcement Kerry Donovan
Contact phone number +64 21 128 7689
Contact email address [email protected]
Date of release through MAP 20/10/2021